Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 3/20 | 0.49 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.42 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.42 |
| ▸ | ITGAL | P20701 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515169 | 1.00 | ECE1 (0.49) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL160994 | 1.00 | ECE1 (0.49) | ECE1ITGB2ICAM1ITGALCA2 | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL22186670 | 0.94 | ECE1 (0.45) | ECE1ITGB2ICAM1ITGALCA2 | |
| N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL22186671 | 0.94 | ECE1 (0.45) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL21381486 | 0.85 | ECE1 (0.45) | ECE1ITGB2ICAM1ITGALCA2 | |
| 1-Aminocyclopropane Carboxylic Acid SCHEMBL15741903 | 0.84 | ECE1 (0.39) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL24915343 | 0.83 | ECE1 (0.44) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL992852 | 0.83 | ECE1 (0.44) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL992850 | 0.83 | ECE1 (0.44) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL15866495 | 0.81 | ECE1 (0.37) | ECE1ITGB2ICAM1ITGALCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2732 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727654-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4720087-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-4720086-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| EP-4663654-A1 | POLYPEPTIDE AND DERIVATIVE THEREOF, COMPOSITION, AND USE THEREOF | Hangzhou Sciwind Biosciences Co., Ltd. (CN) | 2025-12-17 | — | — | EP | claimed |
| EP-4658374-A1 | METHODS FOR PREPARING CRYSTALLINE PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Janssen Pharmaceutica NV (BE) | 2025-12-10 | — | — | EP | claimed |
| EP-4633657-A1 | STAPLED PEPTIDES AND METHODS THEREOF | Parabilis Medicines, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4633656-A1 | STAPLED PEPTIDES AND METHODS THEREOF | Parabilis Medicines, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4622991-A2 | SYNTHESIS OF A CYCLIC PEPTIDE | Janssen Pharmaceutica NV (BE) | 2025-10-01 | — | — | EP | claimed |
| WO-2005073164-A1 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2005-08-11 | — | — | WO | claimed |
| US-5843890-A | Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T | GRUPPO LEPETIT S.P.A. (IT) | 1998-12-01 | — | — | US | claimed |
| US-5747295-A | Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T | GRUPPO LEPETIT S.P.A. (IT) | 1998-05-05 | — | — | US | claimed |
| EP-0529410-B1 | Antibiotic GE 2270 factor C2a | BIOSEARCH ITALIA SPA (IT) | 1998-02-25 | — | — | EP | claimed |
| US-5514649-A | ANIMAL GROWTH REGULATORS; TREATING GRAMNEGATIVE AND GRAMPOSITIVE BACTERIAL INFECTIONS | GRUPPO LEPETIT S.P.A. (IT) | 1996-05-07 | — | — | US | claimed |
| EP-0451486-B1 | Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T | LEPETIT SPA (IT) | 1995-04-19 | — | — | EP | claimed |
| EP-0529410-A2 | Antibiotic GE 2270 factor C2a | GRUPPO LEPETIT S.p.A. (IT) | 1993-03-03 | — | — | EP | claimed |
| WO-1993000108-A1 | NOVEL INHIBITORS OF PLATELET AGGREGATION | CORVAS INTERNATIONAL, INC. (US) | 1993-01-07 | — | — | WO | claimed |
| EP-0451486-A1 | Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T | GRUPPO LEPETIT S.p.A. (IT) | 1991-10-16 | — | — | EP | claimed |
| EP-0410539-A1 | Fibrinogen receptor antagonists | MERCK & CO. INC. (US) | 1991-01-30 | — | — | EP | claimed |